4//SEC Filing
Kayitalire Louis 4
Accession 0001209191-21-019766
CIK 0001566373other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:03 PM ET
Size
5.8 KB
Accession
0001209191-21-019766
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-09+12,880→ 40,169 totalExercise: $7.24Exp: 2031-03-09→ Common Stock (12,880 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 9, 2021, and thereafter in equal monthly installments over the remaining three years.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001831519
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 4:03 PM ET
- Size
- 5.8 KB